Summary
The country’s pharmaceutical sector supplied vaccines to more than 200 nations during the COVID‑19 pandemic, administering over 2.2 billion doses.
Artificial intelligence is highlighted as a tool to accelerate drug discovery, enable personalised medicine and improve disease surveillance, while emphasizing safety and patient privacy.
Government initiatives such as the 5,000‑crore Promotion of Research and Innovation in Pharma‑MedTech Scheme and the 10,000‑crore Biopharma SHAKTI mission aim to strengthen biopharmaceutical capabilities and foster academia‑industry collaboration.
AI centres of excellence have been established at leading medical institutes, and the Ayushman Bharat Digital Mission is creating a nationwide digital health ecosystem with billions of health records.